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The Society for Vascular Surgery® pursued development of clinical practice guidelines for the management of traumatic
thoracic aortic injuries with thoracic endovascular aortic repair. In formulating clinical practice guidelines, the Society selected
a panel of experts and conducted a systematic review and meta-analysis of the literature. They used the Grading of
Recommendations Assessment, Development and Evaluation methods (GRADE) to develop and present their recommenda-
tions. The systematic review included 7768 patients from 139 studies. The mortality rate was significantly lower in patients
who underwent endovascular repair, followed by open repair, and nonoperative management (9%, 19%, and 46%, respectively,
P< .01). Based on the overall very low quality of evidence, the committee suggests that endovascular repair of thoracic aortic
transection is associated with better survival and decreased risk of spinal cord ischemia, renal injury, graft, and systemic
infections compared with open repair or nonoperative management (Grade 2, Level C). The committee was also surveyed on
a variety of issues that were not specifically addressed by the meta-analysis. On these select matters, the majority opinions of the
committee suggest urgent repair following stabilization of other injuries, observation of minimal aortic defects, selective (vs
routine) revascularization in cases of left subclavian artery coverage, and that spinal drainage is not routinely required in these
cases. (J Vasc Surg 2011;53:187-92.)Blunt traumatic thoracic aortic injury is associated with
a high mortality rate, and has been implicated as the second
most common cause of death in trauma patients, behind
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doi:10.1016/j.jvs.2010.08.027only to intracranial hemorrhage.1,2 It has been estimated
that less than 25% of patients with such an injury live to be
evaluated in a hospital,3 and of those who do, up to 50%
will die within 24 hours.4 Given the location of injury in
50% to 70% of cases,4 conventional surgical repair typically
involves a high posterolateral thoracotomy with or without
cardiopulmonary bypass and significant blood loss, which
can negatively impact the pulmonary, cardiac, and neuro-
logic status of the patient. Historically, open repair of
traumatic aortic injuries has been associated with a 28%
mortality rate5 and a 16% paraplegia rate.6 There has been
a risk of delayed rupture in the unrepaired thoracic transec-
tion that has been estimated to be 2% to 5%.7
Thoracic endovascular aortic repair (TEVAR) is a rap-
idly evolving therapy in the treatment of a variety of tho-
racic aortic pathologies. TEVAR involves placing an endo-
vascular stent graft into the thoracic aorta from a remote
peripheral location under imaging guidance. TEVAR offers
the potential for a durable aortic repair while avoiding the
morbidity of a thoracotomy, aortic cross clamping, and
cardiopulmonary bypass. Nevertheless, stroke, spinal cord
ischemia, and other complications that are associated with
open repair can also occur with TEVAR.
Although there is no device currently commercially
available with an on-label indication for repair of trau-
matic thoracic aortic transections, these are increasingly
being treated off-label using endovascular devices. At the
time of this manuscript, there were at least two ongoing
investigator device exemption (IDE) pivotal clinical trials in-
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traumatic thoracic aortic injuries. Despite the focal nature of
these aortic injuries, which may appear to favor endograft
repair, there remains a number of unresolved issues: (1)
poor conformation to the arch, (2) frequent need to cover
the left subclavian artery (LSA), (3) uncertain natural his-
tory of the repair given the younger age of trauma victims
and the morphologic changes of the aorta that come with
age, (4) optimal follow-up strategy that may span several
decades and the risks of cumulative radiation exposure, (5)
timing of repair, and (6) the need for intraoperative anti-
coagulation in the setting of polytrauma.
The Society forVascular Surgery® (SVS) identified several
key issues that require the development of clinical practice
guidelines to aid surgeons, referring physicians, and patients in
the process of decision making. Endovascular repair of trau-
matic thoracic aortic injuries was one of these areas. In devel-
oping these guidelines, the Society utilized similar processes
and formats to their recently published guidelines.8 First, the
Society selected a committee of experts in the field who
possess knowledge of the clinical aspects as well as patients’
values and preferences in this regard. Second, they commis-
sioned the Knowledge and Encounter Research Unit, Mayo
Clinic, Rochester, a third party with expertise in evidence-
based medicine, knowledge synthesis, and guideline devel-
opment to conduct a comprehensive systematic review of
the literature and identify the best available evidence. The
Society acknowledged the value of systematic reviews and
meta-analyses since, compared with individual studies, they
provide evidence that is more robust and more likely to be
applicable to a wider range of patients. Third, the Society
utilized the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) methods to de-
velop and present their recommendations. The GRADE
method provides superior clarity and separates the quality
of evidence from the strength of recommendations. It also
allows for the inclusion of patients’ values and preferences
in recommendations8 (Table I).
In this article, the committee presents the following
recommendation with the aim of clarifying the role of
TEVAR in the treatment of traumatic blunt aortic injuries.
Table I. GRADE (Grading of Recommendations
Assessment, Development, and Evaluation) system
Strength of recommendation Terminology
Grade 1 (strong) “We recommend . . .”
Grade 2 (weak) “We suggest . . .”
Quality of evidence Source of evidence
Level A (high quality) Well conducted randomized trials.
Level B (moderate quality) Less rigorous or inconsistent
randomized trials.
Level C (low or very low
quality)
Observational studies, case series,
and unsystematic observations
or expert opinion.While there was diversity of individual opinions, the articlereflects the consensus of the committee. The recommenda-
tion is followed by the supporting evidence, a values state-
ment, and relevant technical remarks. Detailed description
of the data analysis is in the accompanying article.9
RECOMMENDATION BASED ON THE
META-ANALYSIS
Prospective randomized trials directly comparing open
vs endovascular repair of traumatic thoracic aortic injury are
unavailable. Despite probable clinical equipoise, such a
clinical trial will unlikely be conducted in a timely and
successful manner. Therefore, based on the systematic re-
view of the available literature presented in an article by
Murad et al,9 the committee suggests that endovascular
repair of traumatic thoracic aortic injuries be performed
preferentially over open surgical repair or nonoperative
management. This recommendation is based on very low
quality evidence (Grade 2, Level C).
EVIDENCE
The systematic review commissioned by the Society
included 7768 patients (77% males). The mean ages of
patients treated nonoperatively and with endovascular or
open repair were 39, 39, and 36 years, respectively. The
mortality rate was significantly lower in patients who un-
derwent endovascular repair, followed by open repair and
nonoperative management (9%, 19%, and 46%, respec-
tively, P  .01). The ISS correlated with mortality after
open (P  .01) but not endovascular repair (P .68). No
significant difference in event rate across the three groups
was noted for any stroke. The risk of spinal cord ischemia
(SCI) and end stage renal disease (ESRD) was higher in
open repair compared with endovascular repair and nonop-
erative management (SCI: 9% open vs 3% endovascular and
3% nonoperative, P .01; ESRD: 8% open vs 5% endovas-
cular and 3% nonoperative, P  .01). Compared with
endovascular repair, open repair was associated with in-
creased risk of graft infection and systemic infections, most
commonly pneumonia.With amedian follow-up of 2 years,
there was a trend toward increased risk of a secondary
procedure in endovascular compared with open repair (P
.07).
VALUES
In developing the recommendation that endovascular
repair should be performed preferentially over open surgi-
cal repair or nonoperative management, the committee
placed a significantly higher value on preventing cata-
strophic complications of thoracic aortic repair (death,
stroke, and spinal cord ischemia) and a lower value on
potential adverse events such as endoleak, need for reinter-
vention, and device failures. The committee also placed less
value on possible late-term outcomes that remain unknown
at this time. Furthermore, the committee acknowledges the
off-label use of a medical device in the context of endovas-
cular repair of traumatic thoracic aortic injury, although
there are ongoing studies investigating the safety and effi-
cacy in this application; however, as we believe that pre-
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recommends endovascular repair.
CONSENSUS OF OPINION ON SELECT ISSUES
Endovascular repair of traumatic thoracic aortic injuries
poses several unresolved or controversial issues whose sup-
porting evidence lacks sufficient clarity in the literature due
to cohort heterogeneity, size, and length of follow-up.
Nevertheless, the committee sought to arrive at some con-
sensus on a select number of these issues to offer guidance
in actual clinical practice. To this end, a series of questions
were used to survey the opinions of each committee mem-
ber. Published evidence is provided in support of the ma-
jority and minority opinions when available. Using the
GRADE system, all of the following opinions should be
regarded as Grade 2, Level C statements (Table II).
Issue 1: Timing of TEVAR in a stable patient. The
committee suggests urgent (24 hours) repair barring
other serious concomitant nonaortic injuries, or repair im-
mediately after other injuries have been treated, but at the
latest prior to hospital discharge.10,11 This is consistent
with the available evidence in which mortality was 46% in
those managed nonoperatively.9 While most did not favor
discharge without repair, depending on the severity of the
injury (see below), minority opinion was expressed that
expectant management was appropriate with follow-up im-
aging.
Issue 2: Management of “minimal aortic injury”
(periadventitial defect or hematoma). Intimal or periad-
ventitial defects or hematomas are not infrequently seen on
computed tomography (CT) scan. A classification scheme
for grading the severity of aortic injury has been proposed:
type I (intimal tear), type II (intramural hematoma), type
III (pseudoaneurysm), and type IV (rupture)12 (Fig). The
committee suggests expectant management with serial im-
aging for type I injuries, while types II to IV should be
Table II. Summary of guidelines for thoracic endovascula
Guideline Consensu
Choice of treatment We suggest that endovascular repair
over open surgical repair or nonop
Timing of repair We suggest urgent (24 hours) repa
hospital discharge.
Management of minimal
aortic injury
We suggest expectant management w
I injuries.
Type of repair in the
young patient
We suggest endovascular repair rega
suitable.
Management of left
subclavian artery
We suggest selective revascularizatio
artery.
Systemic heparinization We suggest routine heparinization b
elective TEVAR.
Spinal drainage We do not suggest routine spinal dra
Choice of anesthesia We suggest general anesthesia.
Femoral access technique We suggest open femoral exposure.repaired. This is based on early evidence that most type Iinjuries heal spontaneously.12 Decision to intervene and its
timing should be guided by progression of the initial radio-
graphic abnormality and/or symptoms.
Issue 3: Choice of repair in the young—TEVAR vs
open. There was near unanimity of opinion that anatomic
suitability is important for TEVAR but age should not be a
factor in deciding the type of repair. The risks of death and
spinal cord ischemia are significantly lower in all age groups
after endovascular repair compared with open surgery,13-15
and these early benefits outweigh the concerns of potential
late complications. However, in surgically fit patients with
poor anatomy for endovascular repair, conventional open
repair should be considered.
Issue 4: Suitability and the unmet needs of current
FDA-approved thoracic endografts. With the availabil-
ity of three commercially available devices, there was con-
siderable divergence of opinion about the “best” device for
use in traumatic thoracic aortic injury. There was a consen-
sus, however, that arch conformation represented the sin-
gle greatest unmet need given the curvature of the thoracic
aorta at the location of the injury. Inability to conform to
this curvature can result in malapposition of the endograft,
which can lead to endoleak and endograft collapse.16 The
aortic diameters are relatively smaller in the younger subset
of trauma patients. Currently, available thoracic endograft
sizes mostly reflect the larger aortic diameters that would be
typically encountered in an older cohort with degenerative
aneurysms. Excessive oversizing may result in attachment
site endoleak, device infolding, endograft collapse, and
even death from acute aortic occlusion.16 Endograft col-
lapse represents a failure of the therapy and a marker of
unsuitable anatomy, and open surgical conversion should
be considered. No consensus could be reached regarding
optimal oversizing for these cases, and opinions were
equally divided amongminimal to no oversizing, 5% to 10%
oversizing, and standard oversizing per manufacturer’s rec-
tic repair (TEVAR) in traumatic thoracic aortic injuries
Grade of
recommendation
1—strong
2—weak
Quality of evidence
A—high
B—moderate
C—low or very low
rformed preferentially
ve management.
2 C
d at the latest prior to 2 C
erial imaging for type 2 C
of age if anatomically 2 C
he left subclavian 2 C
a lower dose than in 2 C
. 2 C
2 C
2 Cr aor
s
be pe
erati
ir, an
ith s
rdless
n of t
ut at
inageommendations. Historically, abdominal endograft compo-
f trau
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thoracic devices were either unavailable or anatomically
unsuitable.17,18 Due to the shorter delivery systems, often
these devices could not reach the site of injury from the
femoral approach, which necessitated either use of a longer
makeshift delivery system or access through a more proxi-
mal site. The lengths of extension cuffs are typically short,
and this required multiple overlapping pieces. Such an
intercalating construction allowed slightly improved con-
formation to the arch but at the same time introduced
multiple junctions, which were potential sources of type III
endoleaks.
A number of next generation devices are presently
undergoing clinical trials that may address some of the
unmet needs of this therapy. Cook (Bloomington, Ind) has
recently introduced the Pro-Form delivery system that is
intended to improve arch conformability, and in the near
future the TX2 LP (low-profile), which will decrease the
profile of the delivery catheter and broaden the range of
available diameters. Medtronic (Santa Rosa, Calif) will
introduce the Valiant thoracic endograft with the Cap-
tivia delivery system, which should enhance the stability
and reliability of the deployment mechanism. W. L. Gore
(Flagstaff, Ariz) is currently conducting clinical trials of
their c (conformable)-TAG device, with which prelimi-
nary experience outside the United States appears to
show improved arch conformability and greater toler-
ance to device oversizing.
Issue 5: LSA management during zone 2 coverage.
Fig. Classifications oThere was near unanimity of opinion for selective revascu-larization (either before or after TEVAR) depending on the
status of the vertebral anatomy, with a minority opinion
favoring routine revascularization.19 In the current meta-
analysis,9 the LSAwas covered in 30% of cases. Preservation
of antegrade perfusion on the side of the dominant verte-
bral artery can specifically decrease the risk of posterior
circulation strokes.20 However, the urgency of the repair
and the condition of the victim may preclude preoperative
assessment. If the LSA is covered, intraoperative angiogra-
phy of the right vertebral artery would allow the most
expeditious assessment of the adequacy of the posterior
circulation. If the right vertebral artery is atretic or hypo-
plastic with or without an intact Circle of Willis, the deci-
sion to revascularize the left subclavian artery must be
individualized taking into account the availability of surgi-
cal expertise, condition of the patient, and other injuries.19
Issue 6: Systemic heparinization. The safety of sys-
temic heparinization during endovascular repair in a mul-
tiply injured patient with a closed head injury or abdominal
solid organ injury is a controversial issue. The majority of
committee members indicated that they routinely use sys-
temic heparin but at a lower dose than in elective TEVAR.
A minority opinion was expressed that heparin may not be
necessary as most of these cases can be performed relatively
rapidly, and the risk of a thrombotic event is likely small.21
In the final analysis, the decision must be individualized
based on the balance of the perceived risks of bleeding in a
particular organ system vs the thromboembolic complica-
matic aortic injury.12tions.
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the mainstay of management for spinal cord ischemia dur-
ing TEVAR. The issue of prophylactic spinal drainage is
controversial even for treatment of degenerative thoracic
aneurysms and, to be sure, no data exist for traumatic
injuries. SCI is a low-incidence event (3%) after TEVAR for
traumatic injuries.9 Based on this and the proximal location
of the injury, limited coverage of the thoracic aorta and the
risk of epidural hematoma in a coagulopathic patient, there
was unanimity of opinion that spinal drainage is not rou-
tinely indicated, and it should only be placed for symptoms
of spinal cord ischemia.
Issue 8: Choice of anesthesia—general vs regional
vs local. There was a strong consensus favoring general
anesthesia. While it is possible to perform TEVAR under
local anesthesia (minority opinion), unreliable cooperation
of an agitated trauma patient and presence of concomitant
injuries that may require additional surgery make this op-
tion less favorable.
Issue 9: Femoral access technique—open vs percu-
taneous. Nearly all of the committee members favored
open femoral exposure in these cases to minimize poten-
tially avoidable complications related to percutaneous clo-
sure of large bore access sites. On the other hand, “percu-
taneous TEVAR” using suture-mediated closure devices
can be performed safely with low rates of early and late limb
or life threatening events22 and there was a minority opin-
ion, which favored this approach. In the emergent setting,
percutaneous access can also refer to the actual insertion of
the endovascular device without initial surgical exposure of
the femoral artery. The artery is repaired after the endograft
is deployed by surgical exposure, and removal of the deliv-
ery system under direct vision. This technique may allow a
more rapid endograft delivery and repair in a hemodynam-
ically unstable patient.
Issue 10: Optimal follow-up strategy. Given the
concerns of cumulative radiation, iodinated contrast expo-
sure, and late endograft collapse, the optimal strategy for
long-term follow-up of these patients post-TEVAR re-
mains in evolution. Opinions varied widely within the
committee as to the frequency and types of imaging that
should be utilized. In the absence of any abnormalities on
imaging (ie, stable endograft position, no endoleak) in the
first 12 to 36 months, some have suggested decreasing the
frequency to 2 to 5 years, while others have expressed that,
lacking any evidence to the contrary, follow-up for trau-
matic thoracic aortic injuries should be no different than
those treated with TEVAR for other pathologies. There
was, however, some consensus suggesting that a combina-
tion of a multi-view chest x-ray and a magnetic resonance
angiography (MRA) may be preferable over conventional
contrast computed tomographic angiography (CTA) for
long-term imaging, with due consideration of the metallic
composition of the endograft.
CONCLUSION
Although the quality of evidence is very low, TEVAR
for traumatic thoracic aortic injury is associated with im-proved outcomes compared with open repair, especially
about its lower mortality and incidence of spinal cord
ischemia. However, this finding should be tempered by the
current lack of suitable devices that can accommodate the
unique anatomy of these patients, which has occasionally
resulted in severe procedure-related complications, and the
unknown natural history of the endovascular repair and the
optimal follow-up strategy.
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